BioCentury
ARTICLE | Distillery Techniques

Drug platforms

May 23, 2018 4:19 PM UTC

Structural analyses of NPY1R bound to tool compound antagonists or its endogenous agonist NPY could guide the design of compounds that antagonize or agonize the receptor for obesity, cancer or bone lo...